On January 18, 2021, Baiyu received the notice issued by NMPA(National Medical Products Administration), saying that Baiyu's Pantoprazole Sodium injection has officially passed the Consistency Evaluation, which means NMPA has accredited that Baiyu's Pantoprazole Sodium injection has the same or even better quality and efficacy compared to Reference Listed Drug.